Faculty of Health Sciences, School of Rehabilitation Science, McMaster University, Hamilton, ON, Canada.
School of Rehabilitation Science, McMaster University, Hamilton, Canada.
Cochrane Database Syst Rev. 2024 Feb 28;2(2):CD004871. doi: 10.1002/14651858.CD004871.pub5.
Massage is widely used for neck pain, but its effectiveness remains unclear.
To assess the benefits and harms of massage compared to placebo or sham, no treatment or exercise as an adjuvant to the same co-intervention for acute to chronic persisting neck pain in adults with or without radiculopathy, including whiplash-associated disorders and cervicogenic headache.
We searched multiple databases (CENTRAL, MEDLINE, EMBASE, CINAHL, Index to Chiropractic Literature, trial registries) to 1 October 2023.
We included randomised controlled trials (RCTs) comparing any type of massage with sham or placebo, no treatment or wait-list, or massage as an adjuvant treatment, in adults with acute, subacute or chronic neck pain.
We used the standard methodological procedures expected by Cochrane. We transformed outcomes to standardise the direction of the effect (a smaller score is better). We used a partially contextualised approach relative to identified thresholds to report the effect size as slight-small, moderate or large-substantive.
We included 33 studies (1994 participants analysed). Selection (82%) and detection bias (94%) were common; multiple trials had unclear allocation concealment, utilised a placebo that may not be credible and did not test whether blinding to the placebo was effective. Massage was compared with placebo (n = 10) or no treatment (n = 8), or assessed as an adjuvant to the same co-treatment (n = 15). The trials studied adults aged 18 to 70 years, 70% female, with mean pain severity of 51.8 (standard deviation (SD) 14.1) on a visual analogue scale (0 to 100). Neck pain was subacute-chronic and classified as non-specific neck pain (85%, including n = 1 whiplash), radiculopathy (6%) or cervicogenic headache (9%). Trials were conducted in outpatient settings in Asia (n = 11), America (n = 5), Africa (n = 1), Europe (n = 12) and the Middle East (n = 4). Trials received research funding (15%) from research institutes. We report the main results for the comparison of massage versus placebo. Low-certainty evidence indicates that massage probably results in little to no difference in pain, function-disability and health-related quality of life when compared against a placebo for subacute-chronic neck pain at up to 12 weeks follow-up. It may slightly improve participant-reported treatment success. Subgroup analysis by dose showed a clinically important difference favouring a high dose (≥ 8 sessions over four weeks for ≥ 30 minutes duration). There is very low-certainty evidence for total adverse events. Data on patient satisfaction and serious adverse events were not available. Pain was a mean of 20.55 points with placebo and improved by 3.43 points with massage (95% confidence interval (CI) 8.16 better to 1.29 worse) on a 0 to 100 scale, where a lower score indicates less pain (8 studies, 403 participants; I = 39%). We downgraded the evidence to low-certainty due to indirectness; most trials in the placebo comparison used suboptimal massage doses (only single sessions). Selection, performance and detection bias were evident as multiple trials had unclear allocation concealment, utilised a placebo that may not be credible and did not test whether blinding was effective, respectively. Function-disability was a mean of 30.90 points with placebo and improved by 9.69 points with massage (95% CI 17.57 better to 1.81 better) on the Neck Disability Index 0 to 100, where a lower score indicates better function (2 studies, 68 participants; I = 0%). We downgraded the evidence to low-certainty due to imprecision (the wide CI represents slight to moderate benefit that does not rule in or rule out a clinically important change) and risk of selection, performance and detection biases. Participant-reported treatment success was a mean of 3.1 points with placebo and improved by 0.80 points with massage (95% CI 1.39 better to 0.21 better) on a Global Improvement 1 to 7 scale, where a lower score indicates very much improved (1 study, 54 participants). We downgraded the evidence to low-certainty due to imprecision (single study with a wide CI that does not rule in or rule out a clinically important change) and risk of performance as well as detection bias. Health-related quality of life was a mean of 43.2 points with placebo and improved by 5.30 points with massage (95% CI 8.24 better to 2.36 better) on the SF-12 (physical) 0 to 100 scale, where 0 indicates the lowest level of health (1 study, 54 participants). We downgraded the evidence once for imprecision (a single small study) and risk of performance and detection bias. We are uncertain whether massage results in increased total adverse events, such as treatment soreness, sweating or low blood pressure (RR 0.99, 95% CI 0.08 to 11.55; 2 studies, 175 participants; I = 77%). We downgraded the evidence to very low-certainty due to unexplained inconsistency, risk of performance and detection bias, and imprecision (the CI was extremely wide and the total number of events was very small, i.e < 200 events).
AUTHORS' CONCLUSIONS: The contribution of massage to the management of neck pain remains uncertain given the predominance of low-certainty evidence in this field. For subacute and chronic neck pain (closest to 12 weeks follow-up), massage may result in a little or no difference in improving pain, function-disability, health-related quality of life and participant-reported treatment success when compared to a placebo. Inadequate reporting on adverse events precluded analysis. Focused planning for larger, adequately dosed, well-designed trials is needed.
按摩在治疗颈部疼痛方面被广泛应用,但疗效尚不清楚。
评估按摩与安慰剂或假按摩、无治疗或运动作为辅助治疗急性到慢性持续性颈部疼痛的疗效,这些治疗方法适用于伴有或不伴有神经根病、包括与挥鞭伤相关的疾病和颈源性头痛的成年人。
我们检索了多个数据库(Cochrane 中心对照试验注册库、MEDLINE、EMBASE、CINAHL、循证补充医学数据库、脊椎按摩疗法文献索引),截至 2023 年 10 月 1 日。
我们纳入了比较任何类型的按摩与安慰剂或假按摩、无治疗或等待列表、或按摩作为辅助治疗的随机对照试验(RCTs),这些试验的参与者为急性、亚急性或慢性颈部疼痛的成年人。
我们使用了 Cochrane 预期的标准方法学程序。我们将结局转化为标准化的效应方向(分数越低表示效果越好)。我们使用了一个相对已确定阈值的背景化方法来报告效应大小,从轻微-小、中等到大-实质性。
我们纳入了 33 项研究(1994 名参与者被分析)。选择(82%)和检测(94%)偏倚很常见;多项试验的分配隐藏不清,使用的安慰剂可能不可信,且未测试安慰剂是否有效。按摩与安慰剂(n=10)或无治疗(n=8)进行比较,或作为相同联合治疗的辅助治疗进行评估(n=15)。试验纳入了年龄在 18 岁至 70 岁之间、70%为女性、视觉模拟评分(0 至 100)中疼痛严重程度为 51.8(标准差 14.1)的成年人。颈部疼痛为亚急性-慢性,且分类为非特异性颈部疼痛(85%,包括 n=1 例挥鞭伤)、神经根病(6%)或颈源性头痛(9%)。试验在亚洲(n=11)、美洲(n=5)、非洲(n=1)、欧洲(n=12)和中东(n=4)的门诊环境中进行。试验获得了研究所(15%)的研究资金。我们报告了按摩与安慰剂比较的主要结果。低确定性证据表明,在亚急性和慢性颈部疼痛的 12 周随访中,与安慰剂相比,按摩可能对疼痛、功能障碍和健康相关生活质量没有影响,也可能对患者报告的治疗成功率略有改善。剂量亚组分析显示,高剂量(4 周内至少 8 次、每次至少 30 分钟)可能具有临床重要意义。非常低确定性证据表明总不良事件的发生情况。患者满意度和严重不良事件的数据不可用。疼痛的平均评分是安慰剂组 20.55 分,按摩组为 17.13 分(95%置信区间 8.16 更好到 1.29 更差),疼痛程度用 0 到 100 分表示,分数越低表示疼痛越轻(8 项研究,403 名参与者;I=39%)。我们将证据降级为低确定性,因为存在间接性;安慰剂比较中的大多数试验使用了非最佳的按摩剂量(仅单次治疗)。选择、表现和检测偏倚明显,因为多项试验的分配隐藏不清,使用的安慰剂可能不可信,且未测试安慰剂是否有效。功能障碍的平均评分是安慰剂组 30.90 分,按摩组为 21.21 分(95%置信区间 17.57 更好到 1.81 更好),使用 Neck Disability Index 0 到 100 分表示,分数越低表示功能越好(2 项研究,68 名参与者;I=0%)。我们将证据降级为低确定性,因为存在不精确性(宽置信区间表示仅存在轻微到中度的益处,不能排除或确定具有临床重要意义的变化)和选择、表现和检测偏倚的风险。患者报告的治疗成功率的平均评分是安慰剂组 3.1 分,按摩组为 3.9 分(95%置信区间 1.39 更好到 0.21 更好),使用 1 到 7 分的整体改善量表表示,分数越低表示改善非常明显(1 项研究,54 名参与者)。我们将证据降级为低确定性,因为存在不精确性(单一研究的置信区间很宽,不能排除或确定具有临床重要意义的变化)和表现以及检测偏倚的风险。健康相关生活质量的平均评分是安慰剂组 43.2 分,按摩组为 48.4 分(95%置信区间 8.24 更好到 2.36 更好),使用 SF-12(物理)0 到 100 分表示,分数越低表示健康水平越低(1 项研究,54 名参与者)。我们因不精确性(一项小型研究)和表现以及检测偏倚的风险而将证据降级一次。我们不确定按摩是否会增加总不良事件,如治疗时疼痛、出汗或低血压(RR 0.99,95%置信区间 0.08 至 11.55;2 项研究,175 名参与者;I=77%)。我们将证据降级为非常低确定性,因为存在无法解释的不一致性、表现和检测偏倚以及不精确性(置信区间非常宽,事件总数非常小,即<200 个事件)。
由于在颈部疼痛领域存在大量低确定性证据,按摩对颈部疼痛管理的作用仍不确定。对于亚急性和慢性颈部疼痛(最接近 12 周随访),与安慰剂相比,按摩可能对疼痛、功能障碍、健康相关生活质量和患者报告的治疗成功率没有影响。由于对不良事件的报告不充分,无法进行分析。需要有针对性地规划更大规模、剂量适当、设计良好的试验。